Drug triggers immune cells to attack prostate cancer — Compound kills tumors in mice, human cancer cells in multiple ways Prostate Cancer Research, ResearchVipul PatelMay 28, 2025Prostate Cancer Research, FDA
FDA Approves First Targeted Radioligand Therapy for Metastatic Prostate Cancer — Almost 40% survival improvement with Pluvicto for PSMA-expressing CRPC Prostate Cancer Research, ResearchVipul PatelApril 22, 2025Research, Prostate Cancer Research, FDA
FDA Clears Phase 1 Trial of ARV-110 for Advanced Prostate Cancer Education, Men's Health, Prostate Cancer Awareness, Prostate Cancer Education, Prostate Cancer ResearchVipul PatelJanuary 22, 2020FDA, prostate cancer treatments, Prostate Cancer Awareness, prostate cancer
